Bottom Line Case Study Biopharma companies demonstrate high levels of sourcing and procurement maturity in terms of direct spend with good spend visibility and control in categories such as APIs, intermediates and excipients. However, when it comes to indirect categories, such as MRO, IT, travel, marketing, and professional services, the sector is relatively less mature compared with the automotive and retail industries. Biopharma companies can benefit from advancing beyond the basics in category management as it provides greater visibility and control on the total costs of goods and services. Client The client is a $16 billion-plus global leader in the specialty biopharma industry responsible for developing and delivering medicines for key therapeutic areas such as oncol

Join for free to read